1. Use a pharmaceutical compound, including a compound composed of amphetamine derivatives, the promoter of thyroid 2 receptor, to treat ocular inflammation. The application is divided into 201502485.

• 收藏
• 分享

专利权人:

INC.;ALLERGAN

发明人:

VISWANATH VEENA,BEARD RICHARD L.,DONELLO JOHN E.

申请号：

CL2017002527

公开号：

CL2017002527A1

申请日:

2017.10.06

申请国别(地区):

CL

年份:

2018

代理人:

摘要：

The use of a pharmaceutical compound for the treatment of ocular inflammation is described, including a compound consisting of a phenylurea derivative, which is a promoter of the thyroxine 2 receptor.SE DESCRIBE EL USO DE UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE UN COMPUESTO DERIVADO DE FENILUREA, AGONISTA DEL RECEPTOR DE PÉPTIDO FORMILO 2, PARA TRATAR ENFERMEDADES INFLAMATORIAS OCULARES.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/